Twist Bioscience (TWST) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

TWST Twist Bioscience

Watchlist

42.970
-10.080-19.00%

Close Aug 2 16:00 ET

44.190
+1.220+2.84%

Post 20:01 ET

2.50BMarket Cap-11248P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Twist Bioscience Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Yahoo FinanceAug 3 10:16 ET
TD Cowen Maintains Twist Bioscience(TWST.US) With Buy Rating, Maintains Target Price $65
Moomoo NewsAug 2 16:31 ET · Ratings
Twist Bioscience | 10-Q: Quarterly report
SEC announcementAug 2 16:30 ET · Announcements
Express News | Scorpion Capital (@ScorpionFund) Posts On X "We Remain Short $TWST Twist Bioscience With Strong Conviction That It Is a Zero. Detailed Thoughts on Monday. We're Doing a Fresh, Intensive Round of Research Which We May Publish as a Follow up to Our Nov...
BenzingaAug 2 12:29 ET
Twist Bioscience: A Strong Buy Amid Temporary Setback and Promising Fiscal Year 2024 Outlook
TipRanksAug 2 12:25 ET
Express News | Scorpion Capital - We Remain Short Twist Bioscience - X Post
ReutersAug 2 12:23 ET

Comments

ClydePeternuts

Jul 17 03:06

Cathie Wood and Ark Invest's trade activity from 2024/07/16

Buys🟢\\ $Beam Therapeutics(BEAM.US)$ $Oklo Inc(OKLO.US)$
Sells🔴\\ $Zoom Video Communications(ZM.US)$ $Trimble(TRMB.US)$ $Twist Bioscience(TWST.US)$ $UiPath(PATH.US)$

frankinglily

May 14 03:38

How does the biotech ecosystem support advancements in personalized medicine & genomics?
• Editing Genes | $CRISPR Therapeutics(CRSP.US)$ , $Intellia Therapeutics(NTLA.US)$ , $Beam Therapeutics(BEAM.US)$ , $Verve Therapeutics(VERV.US)$ , $Editas Medicine(EDIT.US)$
• Creating Therapies | $Prime Medicine(PRME.US)$ , $Sana Biotechnology(SANA.US)$
• Building DNA | $Twist Bioscience(TWST.US)$ , $Ginkgo Bioworks(DNA.US)$ , $Pacific Biosciences of California(PACB.US)$ , $Illumina(ILMN.US)$
• Dis...

Moomoo AI

Jan 5 13:12

Twist Bioscience's P/S ratio remains lower due to sub-par revenue outlook, indicating investor expectation of limited future growth. Shareholder pessimism around future revenue growth contributes to this lower ratio.

Twist Bioscience Corporation (NASDAQ:TWST) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

Moomoo AI

Dec 17, 2023 09:14

Twist Bioscience's optimistic cash runway and manageable burn rate are noteworthy despite the need for vigilance as the firm grows. Its market cap also points to easy fundraising potential.

Companies Like Twist Bioscience (NASDAQ:TWST) Are In A Position To Invest In Growth

Moomoo AI

Nov 12, 2023 07:08

Despite Twist Bioscience's unprofitability, rapid revenue growth indicates positive prospects. However, persistent share price decline hints at capital raising issues. Investors should assess the firm's balance sheet, market conditions and specific risks.

Shareholders in Twist Bioscience (NASDAQ:TWST) Have Lost 84%, as Stock Drops 9.6% This Past Week

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

TWST Twist Bioscience

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target